• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Quick Take: HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes

byAliya Ramjaun
September 12, 2019
in Chronic Disease, Endocrinology, Nephrology, Ophthalmology, Pediatrics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Intensive glycemic control has been shown to reduce the risk of retinopathy and nephropathy in the setting of type 1 diabetes. While prior studies have established that an elevated hemoglobin A1C (HbA1C) is an independent risk factor for diabetic complications, few studies have followed patients from the time of diagnosis. In this population-based cohort study, 10,398 children and adults with type 1 diabetes identified through the Swedish National Diabetes Registry (1998-2017) were followed up from diagnosis to study the association between HbA1c level and microvascular complications in individuals with type 1 diabetes. The mean age at diagnosis was 14.7 years. Researchers found that the risk of any retinopathy (simplex or worse) for participants with a HbA1C <6.5% compared to HbA1C 6.5%-6.9% did not significantly differ (OR 0.77, 95% CI 0.56 to 1.05, p=0.10). The risk of retinopathy was, however, increased in participants with HbA1C levels of 7.0%-7.4% (OR 1.31, 95% CI 1.05 to 1.64, p=0.02) as well as those with HbA1C levels of 7.5%-8.6% (OR 2.05, 95% CI 1.68 to 2.51, p<0.001) and >8.6% (OR 3.72, 95% CI 3.02 to 4.58, p<0.001). Researchers also found that compared to patients with HbA1C 6.5%-6.9%, the risk of microalbuminuria or worse was increased in patients with HbA1C 7.0%-7.4% (OR 1.55, 95% CI 1.03 to 2.32, p=0.03) as well as those with HbA1C>8.6% (OR 2.64, 95% CI 1.81 to 3.86, p<0.001). Similarly, the risk of macroalbuminuria was also increased with HbA1C levels >8.6% (OR 3.43, 95% CI 1.14 to 10.26, p=0.03). This study therefore shows that the risk of retinopathy and nephropathy is increased in patients with increased HbA1c levels, above 6.5%-6.9%.

Click to read the study in BMJ

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Weekly insulin efsitora alfa is non-inferior to daily insulin degludec for reducing HbA1c in type 1 diabetes

Machine learning model non-invasively detects suspected cases of hypoglycemia during real-world driving

High dose aflibercept reduced treatment burden in patients with diabetic macular edema

Tags: hemoglobin A1CnephropathyretinopathyType 1 Diabetes Mellitus
Previous Post

#VisualAbstract: Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer

Next Post

Quick Take: Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX)

RelatedReports

Dual VA and Medicare coverage linked to glucose strip overuse
Chronic Disease

Weekly insulin efsitora alfa is non-inferior to daily insulin degludec for reducing HbA1c in type 1 diabetes

October 9, 2024
Pediatric DKA associated with recent acute care visits
2 Minute Medicine

Machine learning model non-invasively detects suspected cases of hypoglycemia during real-world driving

September 13, 2024
Nonpowder gun-related pediatric eye injuries on the rise
Chronic Disease

High dose aflibercept reduced treatment burden in patients with diabetic macular edema

April 23, 2024
#VisualAbstract: Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes
StudyGraphics

#VisualAbstract: Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes

October 13, 2023
Next Post
Prenatal antidepressant exposure may increase risk of poor motor development

Quick Take: Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX)

#VisualAbstract: A Pivotal Response Treatment Package for Children With Autism Spectrum Disorder

#VisualAbstract: A Pivotal Response Treatment Package for Children With Autism Spectrum Disorder

#VisualAbstract: Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome

#VisualAbstract: Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Nerandomilast slows decline in FVC in idiopathic pulmonary fibrosis
  • Mazdutide significantly reduces weight in adults with overweight or obesity
  • Oral vancomycin may be effective for pouchitis in inflammatory bowel disease
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.